Search Results - "Xu, Zhong‐Gao"

Refine Results
  1. 1

    The common risk factors for progression and mortality in COVID-19 patients: a meta-analysis by Zhang, Li, Hou, Jie, Ma, Fu-Zhe, Li, Jia, Xue, Shuai, Xu, Zhong-Gao

    Published in Archives of virology (01-08-2021)
    “…Coronavirus disease 2019 (COVID-19), defined by the World Health Organization (WHO), has affected more than 50 million patients worldwide and caused a global…”
    Get full text
    Journal Article
  2. 2

    Roles of Krüppel‐like factor 5 in kidney disease by Li, Jia, Liu, Liang, Zhou, Wen‐Qian, Cai, Lu, Xu, ZhongGao, Rane, Madhavi J.

    Published in Journal of cellular and molecular medicine (01-03-2021)
    “…Transcription factor Krüppel‐like factor 5 (KLF5) is a member of the Krüppel‐like factors’ (KLFs) family. KLF5 regulates a number of cellular functions, such…”
    Get full text
    Journal Article
  3. 3

    Arginase-1-dependent promotion of TH17 differentiation and disease progression by MDSCs in systemic lupus erythematosus by Wu, Hao, Zhen, Yu, Ma, Zhanchuan, Li, Huimin, Yu, Jinyu, Xu, Zhong-Gao, Wang, Xiang-Yang, Yi, Huanfa, Yang, Yong-Guang

    Published in Science translational medicine (23-03-2016)
    “…Expansion of myeloid-derived suppressor cells (MDSCs) has been documented in some murine models and patients with autoimmune diseases, but the exact role of…”
    Get more information
    Journal Article
  4. 4

    Specific down-regulation of connective tissue growth factor attenuates progression of nephropathy in mouse models of type 1 and type 2 diabetes by Guha, Mausumee, Xu, Zhong-Gao, Tung, David, Lanting, Linda, Natarajan, Rama

    Published in The FASEB journal (01-10-2007)
    “…Diabetic nephropathy (DN) remains a major complication in both type 1 and type 2 diabetes. Systemic administration of antitransforming growth factor-β (TGF-β)…”
    Get full text
    Journal Article
  5. 5

    The Role of Circulating RBP4 in the Type 2 Diabetes Patients with Kidney Diseases: A Systematic Review and Meta-Analysis by Xu, Zhong-Gao, Xue, Shuai, Cheng, Yan-Li, Zhang, Li

    Published in Disease markers (2020)
    “…Background. Diabetic nephropathy is a common and serious complication of diabetes mellitus (DM) and is one of the leading causes of end-stage renal disease…”
    Get full text
    Journal Article
  6. 6

    The Intestinal Microbiota Composition in Early and Late Stages of Diabetic Kidney Disease by Zhang, Li, Lu, Qi-Yu, Wu, Hao, Cheng, Yan-Li, Kang, Jing, Xu, Zhong-Gao

    Published in Microbiology spectrum (17-08-2023)
    “…Many studies have suggested that gut microbiota dysbiosis may be one of the pathogenesis factors of diabetes mellitus (DM), while it is not clear whether it is…”
    Get full text
    Journal Article
  7. 7

    Renal Protective Effect of Sirtuin 1 by Yuan, Hang, Sun, Wei-xia, Wu, Shu-hui, Sun, Tao, Xiao, Zhi, Liu, Nian, Dong, Yi-jun, Xu, Zhong-gao

    Published in Journal of diabetes research (01-01-2014)
    “…Silent information regulator 2 (Sir2) is a nicotinamide adenine dinucleotide- (NAD+-) dependent deacetylase. The homology of SIRT1 and Sir2 has been…”
    Get full text
    Journal Article
  8. 8

    Effect of peritoneal dialysis versus hemodialysis on renal anemia in renal in end-stage disease patients: a meta-analysis by Wang, Wan-Ning, Zhang, Wen-Long, Sun, Tao, Ma, Fu-Zhe, Su, Sensen, Xu, Zhong-Gao

    Published in Renal failure (01-11-2017)
    “…The aim of this meta-analysis was to evaluate the effect of peritoneal dialysis (PD) and hemodialysis (HD) on renal anemia (RA) in renal disease patients by a…”
    Get full text
    Journal Article
  9. 9

    Key Role of Src Kinase in S100B-induced Activation of the Receptor for Advanced Glycation End Products in Vascular Smooth Muscle Cells by Reddy, Marpadga A., Li, Shu-Lian, Sahar, Saurabh, Kim, Young-Sook, Xu, Zhong-Gao, Lanting, Linda, Natarajan, Rama

    Published in The Journal of biological chemistry (12-05-2006)
    “…The receptor for advanced glycation end products (RAGE) and its ligands have been implicated in the activation of oxidant stress and inflammatory pathways in…”
    Get full text
    Journal Article
  10. 10

    12-Lipoxygenase Inhibition on Microalbuminuria in Type-1 and Type-2 Diabetes Is Associated with Changes of Glomerular Angiotensin II Type 1 Receptor Related to Insulin Resistance by Xu, Hong-Zhao, Cheng, Yan-Li, Wang, Wan-Ning, Wu, Hao, Zhang, Yuan-Yuan, Zang, Chong-Sen, Xu, Zhong-Gao

    “…(1) BACKGROUND: 12-lipoxygenase (12-LO) is involved in the development of diabetic nephropathy (DN). In the present study, we investigated whether 12-LO…”
    Get full text
    Journal Article
  11. 11
  12. 12

    Angiotensin II type 1 receptor expression is increased via 12-lipoxygenase in high glucose-stimulated glomerular cells and type 2 diabetic glomeruli by Xu, Zhong-Gao, Miao, Li-Ning, Cui, Ying-Chun, Jia, Ye, Yuan, Hang, Wu, Man

    Published in Nephrology, dialysis, transplantation (01-06-2009)
    “…Background. Angiotensin II type 1 receptor (AT1) plays an important role in the development of diabetic nephropathy (DN). However, the roles played by…”
    Get full text
    Journal Article
  13. 13

    Role of AT-1 receptor in regulation of vascular MCP-1, IL-6, PAI-1, MAP kinase, and matrix expressions in obesity by Vaziri, Nosratola D., Xu, Zhong-Gao, Shahkarami, Ashkan, Huang, Kevin T., Rodruguez-Iturbe, Bernardo, Natarajan, R.

    Published in Kidney international (01-12-2005)
    “…Role of AT-1 receptor in regulation of vascular MCP-1, IL-6, PAI-1, MAP kinase, and matrix expressions in obesity. Metabolic syndrome has emerged as the major…”
    Get full text
    Journal Article
  14. 14

    Products of 12/15-Lipoxygenase Upregulate the Angiotensin II Receptor by XU, Zhong-Gao, HANG YUAN, LANTING, Linda, LI, Shu-Lian, MEI WANG, SHANMUGAM, Narkunaraja, KATO, Mitsuo, ADLER, Sharon G, REDDY, Marpadga A, NATARAJAN, Rama

    “…Angiotensin II and its type 1 receptor (AT1R) play important roles in the pathogenesis of renal disease and diabetic nephropathy. The 12/15-lipoxygenase…”
    Get full text
    Journal Article
  15. 15

    Epigenetic Histone Modifications Involved in Profibrotic Gene Regulation by 12/15-Lipoxygenase and Its Oxidized Lipid Products in Diabetic Nephropathy by Yuan, Hang, Reddy, Marpadga A, Deshpande, Supriya, Jia, Ye, Park, Jung Tak, Lanting, Linda L, Jin, Wen, Kato, Mitsuo, Xu, Zhong Gao, Das, Sadhan, Natarajan, Rama

    Published in Antioxidants & redox signaling (01-03-2016)
    “…Epigenetic mechanisms, including histone post-translational modifications and DNA methylation, are implicated in the pathogenesis of diabetic nephropathy (DN),…”
    Get more information
    Journal Article
  16. 16

    High glucose activates the p38 MAPK pathway in cultured human peritoneal mesothelial cells by Xu, Zhong-Gao, Kim, Kyung Sik, Park, Hyeong Cheon, Choi, Kyu Hun, Lee, Ho Yung, Han, Dae Suk, Kang, Shin-Wook

    Published in Kidney international (01-03-2003)
    “…High glucose activates the p38 MAPK pathway in cultured human peritoneal mesothelial cells. Peritoneal fibrosis is a serious complication in long-term…”
    Get full text
    Journal Article
  17. 17
  18. 18

    Endothelin receptor antagonists for the treatment of diabetic nephropathy: A meta-analysis and systematic review by Zhang, Li, Xue, Shuai, Hou, Jie, Chen, Guang, Xu, Zhong-Gao

    Published in World journal of diabetes (15-11-2020)
    “…Diabetic nephropathy (DN) is the main cause of chronic kidney disease and end-stage renal disease worldwide. Although available clinical trials have shown that…”
    Get full text
    Journal Article
  19. 19

    Roles of 12-Lipoxygenase and Its Interaction with Angiotensin II on p21 and p27 Expression in Diabetic Nephropathy by Zhang, Yuan-Yuan, Wang, Wan-Ning, Su, Sen-Sen, Chen, Bin, Sun, Wei-Xia, Wu, Hao, Cheng, Yan-Li, Xu, Zhong-Gao

    Published in Nephron (2015) (01-01-2019)
    “…12-Lipoxygenase (12-LO) and angiotensin II (Ang II) are involved in the development of diabetic renal hypertrophy, in which cyclin-kinase inhibitors, p21 and…”
    Get more information
    Journal Article
  20. 20

    Meta-analysis of the efficacy and safety of nucleotide/nucleoside analog monotherapy for hepatitis B virus-associated glomerulonephritis by Wang, Wan-ning, Wu, Mei-yan, Ma, Fu-zhe, Sun, Tao, Xu, Zhong-gao

    Published in Clinical nephrology (01-01-2016)
    “…Antiviral monotherapy is recommended for hepatitis B virus-associated glomerulonephritis (HBV-GN) treatment. Although considered superior to interferon-α in…”
    Get more information
    Journal Article